Stay updated on CB-839 in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the CB-839 in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CB-839 in Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Difference
    1%
    Check dated 2025-05-08T13:13:08.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    1%
    Check dated 2025-05-01T05:53:50.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2025-04-23T22:28:55.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of new drug names and the removal of detailed descriptions of a Phase 1 study involving CB-839 for various solid tumors. The revision number has also been updated from v2.14.4 to v2.15.0.
    Difference
    28%
    Check dated 2025-04-16T14:44:24.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.7%
    Check dated 2025-04-09T09:57:47.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to include information on Renal Cell Carcinoma and has been revised to version 2.14.3, while information on Malignant Mesothelioma has been removed.
    Difference
    0.3%
    Check dated 2025-04-01T23:36:34.000Z thumbnail image

Stay in the know with updates to CB-839 in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CB-839 in Solid Tumors Clinical Trial page.